- cafepharma news hand selected daily
- get news headlines in your inbox each weekday
news
Red Orbit
News Tags
Abbott
Alpharma
Amgen
Arena
Astra Zeneca
Biogen
biotech
breast cancer
Bristol-Myers Squibb
buyouts
cancer
Celgene
China
diabetes
drug trials
Elan
Eli Lilly
FDA
Genentech
Gilead
Glaxo
GSK
hepatitis C
Isis
JNJ
Johnson and Johnson
King
layoffs
Lilly
Merck
MS
Mylan
Novartis
Pfizer
Roche
Sanofi-Aventis
Schering-Plough
Teva
Tysabri
Wyeth
New on Cafepharma
- Funny or interesting conversations reps hear in the field
- Keep up with the latest at cafepharma:
- New message boards
- New message board category
While it is understandable from a business viewpoint, this is the type of thing that gives pharma a bad name. I hope they don't harp too much on the "lack of safety" data line. It seems so transparent that it will make the company and industry look even worse.